#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Bronchiolitis Dilated cardiomyopathy Glomerulonephritis chronic Pelizaeus-Merzbacher disease Plasma cell myeloma recurrent Breast angiosarcoma metastatic Bladder cancer Immunoglobulin G4 related disease Non-Hodgkin's lymphoma unspecified histology indolent Carcinoid syndrome Sickle cell anaemia Urethral valves Polymyositis Blastic plasmacytoid dendritic cell neoplasia More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Diagnostics Rhabdomyosarcoma Cytokine release syndrome Hereditary angioedema – Trials in Disease Short-bowel syndrome – Life with Disease Angelman’s syndrome – Trials in Disease Primary hyperoxaluria – Trials in Disease Carcinoid syndrome – Life with Disease Inclusion body myositis – Diagnostics Atypical haemolytic uraemic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dl-Alpha-Tocopherol Arginine Rotigotine Ecoo15 Rbl005.3 Brigatinib Azd2693 Sodium Levonorgestrel [18F]Fapi-74 Ascorbic Acid Bp Alnuctamab Golexanolone Florbetapir (18F) Metoprolol Vibostolimab Azithromycin Mecasermin Rinfabate Glasdegib REGN7999 Fosfomycin More therapies…

    Learn about Your Condition

    Cerebrovascular accident Hyperphagia Rectal cancer recurrent Epicondylitis Hereditary optic atrophy Immune-mediated renal disorder Gout Iron overload Pulmonary vascular disorder Amyotrophic lateral sclerosis Papillary thyroid cancer Alcoholic liver disease Post procedural infection Oropharyngeal cancer recurrent Suicidal ideation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Alcoholic liver disease
    Investigated Drugs:
    • ZALFERMIN
    • Cagrilintide
    • Semaglutide
    Bulgaria Czechia Denmark France Germany Greece +4

  • A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Enalapril Maleate
    • Cagrilintide
    France Greece Hungary Poland Slovakia Spain

  • A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Bulgaria Denmark France Germany Ireland Italy +3

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin
    • Cagrilintide
    • Dapagliflozin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

  • Study of encaleret compared to standard care in patients with autosomal dominant hypocalcemia type 1

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypocalcaemia
    Investigated Drugs:
    • Encaleret Sulfate
    • Alfacalcidol
    • Calcitriol
    Belgium Czechia Denmark France Italy The Netherlands

  • A study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Aspart
    • INSULIN DEGLUDEC
    • Insulin Icodec
    Poland
Previous Page
1 … 32 33 34 35 36 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!